Conference set to showcase innovation in regenerative medicine
A high profile conference providing an opportunity to learn how regenerative medicine research is being translated into clinical benefits for patients is being held at Leeds later this month.
The Regener8 conference on 17 September will focus on The Pathway to Innovation for Regenerative Therapies and will feature some of the latest research being carried out in the rapidly emerging field of regenerative medicine. Expert speaker topics are as diverse as bio-cements for bone regeneration, cellular scaffolds for cardiac repair and regenerative therapies for dental repair.
Hosted by the University in partnership with the Medical Technologies IKC also based in Leeds Regener8 brings together leading academics, industry and clinicians to nurture innovation in regenerative medicine, and translate academic research into products that can be used by clinicians and patients. Regenerative medicine is being used to treat conditions such as diabetes, heart disease, bone fractures, chronic wound management and many others by augmenting or stimulating the body's own repair mechanisms to repair or replace damaged tissue. It is one of the Eight Great Technologies highlighted by the Government as priorities for investment.
Professor John Fisher, Regener8 Executive Director and Director of the University's Institute for Medical and Biological Engineering, said: This is a very exciting time for regenerative medicine, and the UK is at the forefront of developing regenerative therapies much of it underpinned by the partnerships that exist between academics and industry. UK companies are succeeding in commercialising therapies, and an increasingly joined-up community in the UK is helping to bring this about.
Now in its seventh year, the Regener8 Annual Conference provides an opportunity for companies, many of whom are start-ups or SMEs, to share experiences and best practice in taking innovative and highly-specialised regenerative therapies to market.
Professor Fisher continues: Successful translation of regenerative medicine requires a diverse set of expertise - from laboratory tools, imaging techniques right through to developing regenerative devices for organ and tissue repair and protecting intellectual property, so there are lots of opportunities for companies to succeed in this growing market.
The Regener8 Annual Conference offers a great platform to meet a broad spectrum of innovators from industry and academia, all of whom are working towards the goal of technology translation in this highly specialised field.
Wed urge anyone with an interest in regenerative medicine to attend the conference, as it will provide a unique opportunity to expand their awareness and understanding of the latest work developing new therapies for patient benefit.
Visit the Regener8 website for further details of the conference and to book a place.